National Health Investors (NYSE:NHI) Director Robert Mccabe, Jr. Purchases 890 Shares

National Health Investors, Inc. (NYSE:NHI) Director Robert Mccabe, Jr. purchased 890 shares of the stock in a transaction dated Monday, June 15th. The shares were acquired at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares in the company, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

National Health Investors Stock Down 1.9%

Shares of NHI opened at $70.73 on Tuesday. The company’s 50-day moving average price is $77.04 and its 200 day moving average price is $80.03. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The firm has a market cap of $3.43 billion, a P/E ratio of 22.82, a price-to-earnings-growth ratio of 3.87 and a beta of 0.52.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). The company had revenue of $115.13 million for the quarter, compared to analyst estimates of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. National Health Investors’s revenue was up 28.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.15 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, sell-side analysts forecast that National Health Investors, Inc. will post 4.93 earnings per share for the current year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be issued a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.2%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s dividend payout ratio (DPR) is 118.71%.

Hedge Funds Weigh In On National Health Investors

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Norges Bank purchased a new stake in shares of National Health Investors during the fourth quarter worth $55,301,000. JPMorgan Chase & Co. boosted its holdings in National Health Investors by 34.0% in the third quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after purchasing an additional 409,559 shares during the period. Freestone Grove Partners LP acquired a new position in National Health Investors during the 4th quarter worth $21,869,000. Adage Capital Partners GP L.L.C. acquired a new position in National Health Investors during the 4th quarter worth $19,856,000. Finally, Balyasny Asset Management L.P. increased its holdings in National Health Investors by 66.9% during the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock worth $43,121,000 after purchasing an additional 246,486 shares during the period. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. Wells Fargo & Company cut their price objective on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a report on Monday, June 1st. BMO Capital Markets decreased their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday. Truist Financial lowered their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday. Finally, Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $84.57.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.